Raising Representation in Clinical Trials: An Interview with Liz Beatty, Inato

The COVID-19 pandemic created a significant shortage of suitable patients for clinical trials worldwide. Within this crisis was another more serious issue around inclusion and representation, driven by COVID’s disparate effect on certain ethnicities, that spoke to a wider issue...

3 months ago
Clinical Development,Clinical Operations

Raising Representation in Clinical Trials: An Interview with Liz Beatty, Inato

The COVID-19 pandemic created a significant shortage of suitable patients for clinical trials worldwide. Within this crisis was another more serious issue around inclusion and representation, driven by COVID’s disparate effect on certain ethnicities, that spoke to a wider issue...

3 months ago

Building a FAIR Culture in Pharma

The development of a ‘Findable, Accessible, Interoperable and Reusable’ (FAIR) data approach has been an exciting step towards an information-centric approach for the pharmaceutical industry. The potential benefits of this alternative approach to data management and accessibility could significantly support...

4 months ago
R&D,Bioinformatics,Data,News

Building a FAIR Culture in Pharma

The development of a ‘Findable, Accessible, Interoperable and Reusable’ (FAIR) data approach has been an exciting step towards an information-centric approach for the pharmaceutical industry. The potential benefits of this alternative approach to data management and accessibility could significantly support...

4 months ago

Latest Advancements in Parkinson’s Treatment: CGT Shows Potential to Reverse Disease

Every hour, two more people are diagnosed with Parkinson’s in the UK and the global patient population continues to rise. To date, there are no disease-modifying therapies available on the market for Parkinson's (PD) patients. Pharmaceutical company Bayer is simultaneously...

4 months ago
CGT,Clinical Development,News

Latest Advancements in Parkinson’s Treatment: CGT Shows Potential to Reverse Disease

Every hour, two more people are diagnosed with Parkinson’s in the UK and the global patient population continues to rise. To date, there are no disease-modifying therapies available on the market for Parkinson's (PD) patients. Pharmaceutical company Bayer is simultaneously...

4 months ago

Using Translational Research to Bridge the Gap Between Preclinical and Clinical Research

The disparity between animal models and clinical efficacy is compromising the safety and efficacy of therapeutic drugs. Translational research is building the bridge between preclinical studies and therapeutic treatment. Genomic techniques and non-traditional animal models are examples of translational approaches...

4 months ago
R&D,Clinical Development,Clinical Operations,Biology,News

Using Translational Research to Bridge the Gap Between Preclinical and Clinical Research

The disparity between animal models and clinical efficacy is compromising the safety and efficacy of therapeutic drugs. Translational research is building the bridge between preclinical studies and therapeutic treatment. Genomic techniques and non-traditional animal models are examples of translational approaches...

4 months ago

Machine Learning Data Analysis: Applications Across Immunology, Oncology and Diabetes

Computational modelling is becoming increasingly popular for data analysis in life sciences. Vast areas of therapeutic research are taking advantage of machine learning (ML) approaches for disease predictions and pathology. Cancer image analysis and diabetes case prediction are a few...

4 months ago
AI & ML,Data,News

Machine Learning Data Analysis: Applications Across Immunology, Oncology and Diabetes

Computational modelling is becoming increasingly popular for data analysis in life sciences. Vast areas of therapeutic research are taking advantage of machine learning (ML) approaches for disease predictions and pathology. Cancer image analysis and diabetes case prediction are a few...

4 months ago

Understanding the GP Data Extraction Scheme & Use of Patient Data

The General Practice Data for Planning and Research (GPDPR) is a proposed central NHS digital database collating patient data from GP records in England. Originally 1 July 2021, the date for launch has been pushed back to 1 September after...

5 months ago
Clinical Development,Clinical Operations,Data,News

Understanding the GP Data Extraction Scheme & Use of Patient Data

The General Practice Data for Planning and Research (GPDPR) is a proposed central NHS digital database collating patient data from GP records in England. Originally 1 July 2021, the date for launch has been pushed back to 1 September after...

5 months ago

How Has The Covid-19 Pandemic Impacted Oncology and Clinical Operations?

As a part of Proventa’s Clinical Operations and Oncology Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Tanya Russel Kirkpatrick, VP Clinical...

5 months ago
Oncology,Clinical Operations,Biology,News

How Has The Covid-19 Pandemic Impacted Oncology and Clinical Operations?

As a part of Proventa’s Clinical Operations and Oncology Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Tanya Russel Kirkpatrick, VP Clinical...

5 months ago

First Potential Alzheimer’s Drug on the Brink of FDA Approval

On 7 June 2021, Biogen will receive an answer from the FDA regarding the approval of their Alzheimer’s drug, Aducanumab. Approval for this drug will represent a significant milestone in disease management for Alzheimer’s patients, in terms of slowing the...

5 months ago
R&D,Clinical Development,Biology,News

First Potential Alzheimer’s Drug on the Brink of FDA Approval

On 7 June 2021, Biogen will receive an answer from the FDA regarding the approval of their Alzheimer’s drug, Aducanumab. Approval for this drug will represent a significant milestone in disease management for Alzheimer’s patients, in terms of slowing the...

5 months ago

Supporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health

COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...

5 months ago
Clinical Operations,Race and Ethics,Precision and Personalised Medicine,Biology,News

Supporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health

COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...

5 months ago

Innovations in AI Risk-Based Monitoring in Clinical Research

Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...

5 months ago
Clinical Operations,AI & ML

Innovations in AI Risk-Based Monitoring in Clinical Research

Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...

5 months ago